Cancer Patients Get Groundbreaking Round-The-Clock AI Support

Wolfson Medical Center in Holon, near Tel Aviv, is using artificial intelligence to monitor and interact with female cancer patients as they undergo chemotherapy as part of a revolutionary new partnership with XOLTAR AI company. 

Patients will receive personal, round-the-clock support tailored to their individual needs based on data analyzed by AI. The program was developed by XOLTAR in conjunction with Wolfson’s Gynecologic Oncology Department, which is headed by Prof. Talia Levy. 

The software allows patients to hold daily video meetings via virtual consultants, during which they can discuss their physical and mental state as well as any side effects they may be experiencing after each round of treatment they receive.

The virtual consultants, which are available all day every day, also act as a liaison between the patient and her team of caregivers. 

XOLTAR calls the project “an AI-based personalizable program that will accompany patients who receive chemotherapy via interactive video conversations with our virtual AI-based agents.” 

Dr. Ornit Cohen, the head of Innovation and R&D at Wolfson Medical Center praised the program, which she said can help make cancer treatment more effective. 

“Cancer is known to be a disease that severely affects the mental state of those afflicted by it, which then affects the immune system and the wellbeing of the patients. We believe that through the unique accompaniment experience developed by XOLTAR, we can help patients undergoing chemotherapy and make their treatment more effective and reduce some of the emotional burden they must bear.”